SmarTrend Watching for Potential Pullback in Shares of Penn Virginia After 1.44% Gain
Comtex SmarTrend(R) - Mon Jun 30, 5:32PM CDT
Penn Virginia (NYSE
pSivida Corp. Reports Positive Regulatory Outcome for ILUVIEN(R); Moves to National Phase for Marketing Authorizations in 10 More EU Countries
Business Wire - Mon Jun 30, 6:35AM CDT
pSivida Corp. (NASDAQ: PSDV)(ASX: PVA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that the regulatory process for marketing authorizations in Belgium, the Czech Republic, Denmark, Finland, Ireland, Luxembourg, the Netherlands, Norway, Poland and Sweden has entered the national phase following the successful completion of the Mutual Recognition Procedure (MRP) for subsequent authorizations. In the national phase, each of these countries will grant a marketing authorization for ILUVIEN for the treatment of vision impairment associated with chronic DME considered insufficiently responsive to available therapies. ILUVIEN initially received marketing authorizations in Austria, France, Italy, Portugal, Spain as well as the United Kingdom and Germany where it is now commercially available.
NYSE stocks posting largest percentage increases
AP - Thu Jun 26, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
Penn Virginia Corp. (PVA) Surges: Stock Adds 12.3% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jun 26, 7:40AM CDT
Penn Virginia Corporation (PVA) was a big mover last session, as the company saw its shares rise more than 12% on the day.
Why Penn Virginia, Hanesbrands, and zulily Jumped Today
Dan Caplinger, The Motley Fool - Motley Fool - Wed Jun 25, 7:04PM CDT
Wednesday proved to be another example of the resiliency of the bull market in stocks, as major market benchmarks bounced back from yesterday's losses to regain a substantial chunk of their lost ground. Even though U.S. GDP figures for the first...
Why Penn Virginia Corporation's Stock Soared Today
Travis Hoium, The Motley Fool - Motley Fool - Wed Jun 25, 4:15PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Penn Virginia jumped 12% today after...
Why Penn Virginia (PVA) Stock Is Up Today
at The Street - Wed Jun 25, 2:22PM CDT
Penn Virginia (PVA) is gaining Wednesday after the Soros Fund called for the company to sell itself.
Status Report, Stock Offerings, Manufacturing Updates, and Dividends - Analyst Notes on Range, Huntsman, Hercules Offshore, Sanchez Energy and Penn Virginia
PR Newswire - Wed Jun 25, 5:00AM CDT
Today, Analysts Review released its analysts' notes regarding Range Resources Corp. (NYSE: RRC), Huntsman Corporation (NYSE: HUN), Hercules Offshore, Inc. (NASDAQ: HERO), Sanchez Energy Corp (NYSE: SN) and Penn Virginia Corporation (NYSE: PVA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4085-100free.
Watch for Penn Virginia to Potentially Pullback After Gaining 2.91% Yesterday
Comtex SmarTrend(R) - Mon Jun 23, 5:49PM CDT
Penn Virginia (NYSE
Here's Why Penn Virginia's Shares Are Undervalued
Rupert Hargreaves, The Motley Fool - Motley Fool - Mon Jun 23, 10:40AM CDT
There was plenty of fuss about Penn Virginia Corporation's potential earlier this year after billionaire investor George Soros' fund took a 9.2% stake in the company. Since this announcement, however, the company's shares have retreated....
pSivida Announces ILUVIEN(R) Receives Marketing Authorization in Italy for Treatment of Chronic Diabetic Macular Edema
Business Wire - Mon Jun 23, 8:38AM CDT
pSivida Corp. (NASDAQ: PSDV) (ASX: PVA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that the Italian Medicines Agency (Agenzia Italiana del Farmaco) has granted marketing authorization to ILUVIEN(R) for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies.
Penn Virginia Corporation Declares Dividend on Series A Preferred Depositary Shares
GlobeNewswire - Fri Jun 20, 8:58AM CDT
The Board of Directors of Penn Virginia Corporation (NYSE
Why Are Penn Virginia's Shares Sliding?
Rupert Hargreaves, The Motley Fool - Motley Fool - Tue Jun 17, 9:52AM CDT
Since releasing its first quarter results at the beginning of May, Penn Virginia's shares have been falling. Penn Virginia reported a first quarter loss per share of $0.12, worse than analyst expectations, which called for a loss of $0.06 per...
After Yesterday's Rally of 4.04% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Fri Jun 13, 4:39PM CDT
Penn Virginia (NYSE
Upgrade Alert for Penn Virginia (PVA)
Comtex SmarTrend(R) - Fri Jun 13, 7:04AM CDT
Penn Virginia (NYSE
Penn Virginia Corporation Announces Pricing of Private Offering of $275 Million of Depositary Shares Representing Convertible Preferred Stock
GlobeNewswire - Wed Jun 11, 7:55AM CDT
Penn Virginia Corporation (NYSE
Penn Virginia Corporation Announces Proposed Private Offering of $250 Million of Depositary Shares Representing Convertible Preferred Stock
GlobeNewswire - Tue Jun 10, 4:02PM CDT
Penn Virginia Corporation (NYSE
Ongoing Exploration Update, Redemption of Notes, Over-Allotment Option, Asset Sale, and Acquisition - Analyst Notes on IAMGOLD, Continental, Encana, Penn Virginia and Oceaneering
PR Newswire - Fri Jun 06, 5:00AM CDT
Today, Analysts Review released its analysts' notes regarding IAMGOLD Corp. (NYSE: IAG), Continental Resources Inc. (NYSE: CLR), Encana Corporation (NYSE: ECA), Penn Virginia Corporation (NYSE: PVA) and Oceaneering International, Inc. (NYSE: OII). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/3428-100free.